Enoxaparin for Early Anticoagulation after Mitral Valve Repair

Journal Title: Cardiology and Angiology: An International Journal - Year 2015, Vol 3, Issue 4

Abstract

Introduction: Despite recent progress and technological advances, heart valve surgery remains associated with a high rate of thromboembolic complications requiring anticoagulation, which must be both safe and effective to prevent any thromboembolic or bleeding events. Objectives: The objective of this study was to verify the efficacy and the safety of Low Molecular Weight Heparin followed by vitamin K antagonists for the early anticoagulation after mitral valve repair. Patients and Methods: This work was conducted as a prospective study. We selected 120 consecutive patients who underwent mitral valve repair and received enoxaparin as bridge between continuous unfractionated heparin and fully effective vitamin K antagonist therapy. The mean age was 63.6±13.5 years (15-84 years). Results: There was no in-hospital mortality. One bleeding event (0.8%) was described: a right haemothorax drained percutaneously with transfusion and no thrombo-embolic events. Conclusion: Low molecular weight heparin enoxaparin as bridging therapy between immediate postoperative unfractionated heparin and complete efficacy of oral anticoagulants may be considered as an option for the prevention of thromboembolic events in patients recently undergoing mitral valve repair.

Authors and Affiliations

Younes Moutakiallah, Roland Henaine, Mehdi Bamous, Jacques Robin, Jean Ninet, Jean-François Obadia

Keywords

Related Articles

Congestive Heart Failure among the Libyan Population (North Africa); A Community Based Survey of Risk Factors and Complication

Congestive Heart failure (CHF) is a very common medical disorder and a major health problem in Libya. CHF is associated with an increase in the risk of stroke and hospitalization. Objectives: To estimate and describe th...

β-blockers in Post ST Elevation Myocardial Infarction Patient with Low Left Ventricular Systolic Function: A Retrospective Study at Shahid Gangalal National Heart Centre, Kathmandu, Nepal

Aims: Despite well developed guidelines in the management of ST elevation myocardial infarction with low left ventricular ejection fraction, β-blockers remain an underutilized therapy. We aim to assess the adherence of β...

Kindergarten Children with Congenital Heart Disease Show Good Physical Activity but Reduced Motor Skills in Comparison with Healthy Children

Objective: For the interaction of individuals with their environment, motor competence is of major importance. It is known that school children with congenital heart disease (CHD) have motoric limitations even without he...

Angiosarcoma of Large Intestine: A Case Report

Angiosarcomas are collectively one of the rare forms of soft tissue neoplasms. That of the large intestine is much rarer. We report a case of large intestinal angiosarcoma. This is a case of a 30-year-old man who present...

Use of Levosimendan in Patients With Low Left Ventricular Ejection Fraction in Ordu/Turkey: Report of Experience with Mini Review

Aims:To report the effect of prophylactic usage of levosimendan in patients with low left ventricular ejection fraction undergoing coronary artery bypass grafting (CABG). Methods: We reported early results of 32 patients...

Download PDF file
  • EP ID EP343927
  • DOI 10.9734/CA/2015/17779
  • Views 72
  • Downloads 0

How To Cite

Younes Moutakiallah, Roland Henaine, Mehdi Bamous, Jacques Robin, Jean Ninet, Jean-François Obadia (2015). Enoxaparin for Early Anticoagulation after Mitral Valve Repair. Cardiology and Angiology: An International Journal, 3(4), 175-180. https://europub.co.uk/articles/-A-343927